Wright S C, Jewett A, Mitsuyasu R, Bonavida B
Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, CA 90024.
J Immunol. 1988 Jul 1;141(1):99-104.
Peripheral blood monocytes (PBM) from AIDS patients have exhibited defects in some but not all of the immune functions yet tested. This study has examined the capacity of AIDS PBM to lyse tumor target cells as well as their ability to secrete TNF. Untreated PBM from AIDS patients were significantly cytotoxic to U937 target cells and responded to IFN-gamma pretreatment with augmented cytotoxicity. Both the spontaneous and IFN-gamma-stimulated cytotoxic activity was significantly (p less than 0.01) higher than that observed with normal PBM. The cytotoxic activity depended on the E:T ratio used and was higher in AIDS PBM at all ratios tested (10:1 to 40:1). Because TNF has been implicated in macrophage cell-mediated cytotoxicity, we examined whether the elevated cytotoxic activity of AIDS PBM was associated with an increase in TNF production. Supernatants from PBM cultured overnight with or without IFN-gamma were tested in a bioassay measuring cytotoxicity against U937 target cells as well as in an RIA specific for TNF. Supernatants derived from either unstimulated or IFN-gamma-treated AIDS PBM exhibited significantly higher levels of cytotoxicity than supernatants from normal macrophages. Both normal and AIDS PBM produced higher levels of cytotoxic factors in response to IFN-gamma. As determined by the RIA, AIDS PBM spontaneously released high levels of TNF whereas little TNF was produced by normal PBM. Treatment with IFN-gamma augmented the level of TNF production in both AIDS and normal PBM. These results demonstrate that PBM from AIDS patients have undergone in vivo activation as manifested by both cytotoxicity against tumor target cells and production of TNF. Target cell lysis by both AIDS PBM and their supernatants was inhibited by monoclonal anti-rTNF, suggesting that the increase in PBM cell-mediated cytotoxicity was caused by an increase in TNF production. The significance of these findings in the pathogenesis of the disease is discussed.
艾滋病患者的外周血单核细胞(PBM)在已检测的部分而非全部免疫功能中表现出缺陷。本研究检测了艾滋病患者PBM裂解肿瘤靶细胞的能力及其分泌肿瘤坏死因子(TNF)的能力。未经处理的艾滋病患者PBM对U937靶细胞具有显著的细胞毒性,并且对γ干扰素预处理有增强的细胞毒性反应。自发的和γ干扰素刺激的细胞毒性活性均显著高于正常PBM(p<0.01)。细胞毒性活性取决于所用的效靶比(E:T),在所有测试的比例(10:1至40:1)下,艾滋病患者PBM的细胞毒性活性均更高。由于TNF与巨噬细胞介导的细胞毒性有关,我们研究了艾滋病患者PBM升高的细胞毒性活性是否与TNF产生增加有关。将PBM在有或没有γ干扰素的情况下培养过夜的上清液,在测量对U937靶细胞细胞毒性的生物测定中以及在针对TNF的放射免疫分析(RIA)中进行检测。来自未刺激或γ干扰素处理的艾滋病患者PBM的上清液,其细胞毒性水平显著高于正常巨噬细胞的上清液。正常和艾滋病患者PBM在γ干扰素刺激下均产生更高水平的细胞毒性因子。通过RIA测定,艾滋病患者PBM自发释放高水平的TNF,而正常PBM几乎不产生TNF。γ干扰素处理增强了艾滋病患者和正常PBM中TNF的产生水平。这些结果表明,艾滋病患者的PBM已在体内被激活,表现为对肿瘤靶细胞的细胞毒性和TNF的产生。单克隆抗rTNF抑制了艾滋病患者PBM及其上清液对靶细胞的裂解,表明PBM细胞介导的细胞毒性增加是由TNF产生增加引起的。本文讨论了这些发现对该疾病发病机制的意义。